Prognostic value of stem cell quantification in stage II colon cancer.

Silvers et al., “Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer,” The Prostate , vol.

Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.. Initiation of human

In order to evaluate the percentage of cancer stem cells in the total HepG2 cell population following exposure to low-dose cisplatin, cells were labeled with the cancer stem

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. British journal

This work describes the development of a label free immunosensor based on screen-printed AuNPs/carbon and the characterization of its analytical response for staphylococcal

These findings extend to heterogeneous tumour phenotype, as defined by gene expression, the idea that differences in methyl- ation patterns in stem cell genes are a hallmark of

Here, we have sorted HCC cells using CD133 as a cancer stem cell (CSC) marker by magnetic-activated cell sorting (MACS) and demonstrated that the CD133 + HCC cells not only

Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients.. Bernd Schmidt 1 , Julia